UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer trial tests combo therapy against single drug
Disease control Recruiting nowThis study tests whether adding a targeted chemotherapy procedure (TACE) to the drug lenvatinib works better than lenvatinib alone for people with liver cancer that cannot be removed by surgery. About 40 adults with early to advanced liver cancer will be enrolled. The goal is to …
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Radioactive beads aim to shrink inoperable liver tumors
Disease control Recruiting nowThis early-stage trial tests a single injection of MDN-001, which contains tiny radioactive beads (Yttrium-90), in 40 people with liver cancer that cannot be removed by surgery. The goal is to see if the treatment is safe and can shrink tumors, slow disease progression, and impro…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1 • Sponsor: Suzhou Mednovo Yi Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC